Diagnosis of Adrenal Insufficiency: Evaluation of the Corticotropin-Releasing Hormone Test and Basal Serum Cortisol in Comparison to the Insulin Tolerance Test in Patients with Hypothalamic-Pituitary-Adrenal Disease
The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Abstract
The aim of the study was to evaluate the diagnostic value of the human CRH test and the basal morning serum cortisol for the diagnosis of adrenal insufficiency. Putative peak cortisol cut points for the CRH test and basal cortisol cut points were determined by receiver operating characteristic (ROC) analysis with the insulin tolerance test as reference test. Fifty-four patients with suspected hypothalamic-pituitary-adrenal disease were tested. In 20 healthy controls, CRH led to a mean peak cortisol of 594.8 +/- 21.7 nmol/liter. The lower limit of a normal response was calculated as 400 nmol/liter. ROC analysis of peak cortisol levels during CRH testing of patients with suspected hypothalamic-pituitary-adrenal disease suggested an optimal peak cortisol cut point of < or 377 nmol/liter for the diagnosis of adrenal insufficiency and a 96% specificity but poor sensitivity of 76%. The baseline cortisol in the healthy control group showed a mean of 439.3 +/- 24.9 nmol/liter, resulting in a lower limit of 267 nmol/liter. ROC analysis of patients suggested the highest accuracy for basal cortisol levels of 285 nmol/liter or more for the diagnosis of adrenal insufficiency (100% sensitivity and 61% specificity). Within this patient group, a cortisol of more than 98 nmol/liter excluded adrenal insufficiency among those without the disorder, yielding 100% specificity. Using these criteria of upper (285 nmol/liter) and lower (98 nmol/liter) cut-off points with high sensitivity and specificity can reduce the number of individuals who need provocative tests. Basal cortisol is less expensive, and we therefore suggest to use it as a first-line test of adrenal insufficiency. Because of the low sensitivity of the human CRH test, we do not recommend it as a second test.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“It should be noted that the choice of what morning cortisol concentration to utilize to rule out adrenal insufficiency (100% sensitivity) is controversial, with studies arguing levels from Ͼ285 nmol/L (10.3 g/dL) (23) to Ͼ480 nmol/L (17 g/dL) (62).”
From Diagnosis and Treatment of Primary Adrenal Insufficiency: An Endocrine Society Clinical Practice Guideline (2016) · cites this paper as [23]
In the citing paper
“Unfortunately, most of the primary reports detailing this cutoff value are not based on subjects with PAI (23,24,(61)(62)(63)(64).”
From Diagnosis and Treatment of Primary Adrenal Insufficiency: An Endocrine Society Clinical Practice Guideline (2016) · cites this paper as [23]
In the citing paper
“Varying cutoffs for basal cortisol levels have been suggested to predict AI [11, 17-19, 41].”
From New Cutoffs for the Biochemical Diagnosis of Adrenal Insufficiency after ACTH Stimulation using Specific Cortisol Assays (2021) · cites this paper as [17]
In the citing paper
“CRH stimulation test is not commonly used because of the high cost of the CRH peptide and low sensitivity for detecting AI [53].”
From Glucocorticoid withdrawal-an overview on when and how to diagnose adrenal insufficiency in clinical practice (2021) · cites this paper as [53]
Citations
Cites
Schlaghecke, R., Kornely, E., Santen, R. T., & Ridderskamp, P. (1992) · New England Journal of Medicine · doi:10.1056/nejm199201233260403 · Cited by 381
Corticotropin-Releasing Hormone in Humans*
ORTH, D. N. (1992) · Endocrine Reviews · doi:10.1210/edrv-13-2-164 · Cited by 282
Value of basal plasma cortisol assays in the assessment of pituitary-adrenal insufficiency
HÄGG, E., ASPLUND, K., & LITHNER, F. (1987) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1987.tb00780.x · Cited by 233
Nieman, L. K. (1993) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.77.5.1308 · Cited by 231
Toogood, A. A., Beardwell, C. G., & Shalet, S. M. (1994) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1994.tb02583.x · Cited by 219
SCHÜRMEYER, T. H., AVGERINOS, P. C., GOLD, P. W., GALLUCCI, W. T., TOMAI, T. P., CUTLER, G. B., LORIAUX, D. L., & CHROUSOS, G. P. (1984) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-59-6-1103 · Cited by 206
Evaluation of the Integrity of the Hypothalamic-Pituitary-Adrenal Axis by Insulin Hypoglycemia Test1
Erturk, E., Jaffe, C. A., & Barkan, A. L. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.7.4980 · Cited by 204
Jones, S. L., Trainer, P. J., Perry, L., Wass, J. A. H., Besser, G. M., & Grossman, A. (1994) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1994.tb03793.x · Cited by 159
LYTRAS, N., GROSSMAN, A., PERRY, L., TOMLIN, S., WASS, J. A. H., COY, D. H., SCHALLY, A. V., REES, L. H., & BESSER, G. M. (1984) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1984.tb00061.x · Cited by 142
Trainer, P. J. (1995) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.80.2.412 · Cited by 76
Cited by
Bornstein, S. R., Allolio, B., Arlt, W., Barthel, A., Don-Wauchope, A., Hammer, G. D., Husebye, E. S., Merke, D. P., Murad, M. H., Stratakis, C. A., et al. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-1710 · Cited by 1,769
“Itshouldbenotedthatthechoiceofwhatmorningcortisol concentration to utilize to rule out adrenal insufficiency (100% sensitivity) is controversial, with studies arguing lev-elsfrom (cid:4) 285nmol/L(10.3 (cid:2) g/dL)(23)to (cid:4) 480nmol/L(17 (cid:2) g/dL) (62).”
BackgroundInfluentialHormonal Replacement in Hypopituitarism in Adults: An Endocrine Society Clinical Practice Guideline
Fleseriu, M., Hashim, I. A., Karavitaki, N., Melmed, S., Murad, M. H., Salvatori, R., & Samuels, M. H. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-2118 · Cited by 945
Charmandari, E., Nicolaides, N. C., & Chrousos, G. P. (2014) · The Lancet · doi:10.1016/s0140-6736(13)61684-0 · Cited by 644
Hahner, S., Ross, R. J., Arlt, W., Bancos, I., Burger-Stritt, S., Torpy, D. J., Husebye, E. S., & Quinkler, M. (2021) · Nature Reviews Disease Primers · doi:10.1038/s41572-021-00252-7 · Cited by 223
Pituitary Dysfunction After Traumatic Brain Injury: A Clinical and Pathophysiological Approach
Tanriverdi, F., Schneider, H. J., Aimaretti, G., Masel, B. E., Casanueva, F. F., & Kelestimur, F. (2015) · Endocrine Reviews · doi:10.1210/er.2014-1065 · Cited by 218
Javorsky, B. R., Raff, H., Carroll, T. B., Algeciras-Schimnich, A., Singh, R. J., Colón-Franco, J. M., & Findling, J. W. (2021) · Journal of the Endocrine Society · doi:10.1210/jendso/bvab022 · Cited by 171
“Basal morning serum cortisol concentrations are also used to either increase the suspicion for, or rule-out the diagnosis of AI [11, 12, 17-20].”
BackgroundMethodWoods, C. P., Argese, N., Chapman, M., Boot, C., Webster, R., Dabhi, V., Grossman, A. B., Toogood, A. A., Arlt, W., Stewart, P. M., et al. (2015) · European Journal of Endocrinology · doi:10.1530/eje-15-0608 · Cited by 152
Maghnie, M., Uga, E., Temporini, F., Di Iorgi, N., Secco, A., Tinelli, C., Papalia, A., Casini, M., & Loche, S. (2005) · European Journal of Endocrinology · doi:10.1530/eje.1.01911 · Cited by 120
“Although the results of CRH testing have been reported to correlate with those of ITT in patients with glucocorticoid-induced corticotropin deficiency (18, 20, 27), the CRH test has not generally been regarded as a useful tool in the clinical setting ( 20 , 27).”
MethodPredictive Value of Circulating Insulin-Like Growth Factor I Levels in Ischemic Stroke Outcome
Bondanelli, M., Ambrosio, M. R., Onofri, A., Bergonzoni, A., Lavezzi, S., Zatelli, M. C., Valle, D., Basaglia, N., & degli Uberti, E. C. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-1040 · Cited by 108
“A peak response 21 g/dl or greater (600 nmol/liter) was considered normal (19).”
BackgroundBerg, C., Meinel, T., Lahner, H., Yuece, A., Mann, K., & Petersenn, S. (2010) · European Journal of Endocrinology · doi:10.1530/eje-09-0824 · Cited by 105
Self-citationBondanelli, M., Ambrosio, M. R., Cavazzini, L., Bertocchi, A., Zatelli, M. C., Carli, A., Valle, D., Basaglia, N., & Uberti, E. C. D. (2007) · Journal of Neurotrauma · doi:10.1089/neu.2007.0343 · Cited by 104
“Patients with basal serum cortisol of (cid:4) 3.5 (cid:2) g/dL (98 nmol/L) and (cid:7) 11 (cid:2) g/dL (285 nmol/L) underwent a low-dose (1.0 (cid:2) g) ACTH test (Schmidt et al. 2003).”
InfluentialTanriverdi, F., Unluhizarci, K., & Kelestimur, F. (2010) · Pituitary · doi:10.1007/s11102-009-0215-x · Cited by 103
“Dynamic tests are required for the diagnosis of ACTH deficiency unless the basal cortisol level is less than 98 nmol/L (3.5 lg/dL), and when the basal cortisol level is higher than 500 nmol/L (18 lg/dL) pituitary-adrenal axis could be accepted as normal without performing any dynamic test [ 34 ].”
MethodInfluentialAssociation between Adrenal Insufficiency and Ventilator Weaning
Huang, C.-J., & Lin, H.-C. (2006) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200504-545oc · Cited by 84
Nandagopal, R., Sinaii, N., Avila, N. A., Van Ryzin, C., Chen, W., Finkielstain, G. P., Mehta, S. P., McDonnell, N. B., & Merke, D. P. (2011) · European Journal of Endocrinology · doi:10.1530/eje-11-0019 · Cited by 81
Deutschbein, T., Broecker-Preuss, M., Flitsch, J., Jaeger, A., Althoff, R., Walz, M. K., Mann, K., & Petersenn, S. (2012) · European Journal of Endocrinology · doi:10.1530/eje-11-0945 · Cited by 81
Self-citationInvestigation of the Hypothalamo-pituitary-adrenal (HPA) axis: a contemporary synthesis
Karaca, Z., Grossman, A. B., & Keleştimur, F. (2021) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-020-09611-3 · Cited by 83
“8 μg/dl) and a lower cut-off level of 98 nmol/l (3 μg/dl) were shown to reduce the number of subjects requiring stimulation tests [17].”
BackgroundMethodAnatomy, Physiology, and Laboratory Evaluation of the Pituitary Gland
Hong, G. K., Payne, S. C., & Jane, J. A. (2015) · Otolaryngologic Clinics of North America · doi:10.1016/j.otc.2015.09.002 · Cited by 74
The diagnosis and investigation of adrenal insufficiency in adults
Wallace, I., Cunningham, S., & Lindsay, J. (2009) · Annals of Clinical Biochemistry: International Journal of Laboratory Medicine · doi:10.1258/acb.2009.009101 · Cited by 68
Pituitary dysfunction following traumatic brain injury: clinical perspectives
Tanriverdi, F., & Kelestimur, F. (2015) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s65814 · Cited by 65
“5 μg/dL (98 nmol/L) and 18 μg/dL (500 nmol/L) and clinical findings suggest ACTH deficiency, an appropriate dynamic test needs to be performed before discharge.(54) In addition, TSH deficiency could be evaluated by measuring basal free T4 and TSH levels when the patient is stable before discharge.”
Adrenocortical Insufficiency in Horses and Foals
Hart, K. A., & Barton, M. H. (2011) · Veterinary Clinics of North America Equine Practice · doi:10.1016/j.cveq.2010.12.005 · Cited by 72
Endocrine Dysfunction After Traumatic Brain Injury: An Ignored Clinical Syndrome?
Mahajan, C., Prabhakar, H., & Bilotta, F. (2023) · Neurocritical Care · doi:10.1007/s12028-022-01672-3 · Cited by 65
“Hyponatremia, hypoglycemia, hyponatremia, and a morning serum cortisol value less than 3.5 μg/dl strongly indicate adrenal insufficiency [36] (Table 1).”
BackgroundInfluentialCushing's disease: predicting long-term remission after surgical treatment
Pendharkar, A. V., Sussman, E. S., Ho, A. L., Hayden Gephart, M. G., & Katznelson, L. (2015) · Neurosurgical Focus · doi:10.3171/2014.10.focus14682 · Cited by 51
“22,39,53 In general, results have been highly variable in determining useful criteria for evaluating CRH stimulation data, and there has been no established added benefit over measurement of static serum cortisol levels.”
BackgroundDeutschbein, T., Unger, N., Mann, K., & Petersenn, S. (2009) · European Journal of Endocrinology · doi:10.1530/eje-08-0600 · Cited by 52
“(43) as well as ourselves (11) published lower values, while Jones et al.”
BackgroundSelf-citationPrevalence of opioid-induced adrenal insufficiency in patients taking chronic opioids
Li, T., Cunningham, J. L., Gilliam, W. P., Loukianova, L., Donegan, D. M., & Bancos, I. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa499 · Cited by 51
Diagnosis and Treatment of Adrenal Insufficiency in the Critically Ill Patient
Asare, K. (2007) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.27.11.1512 · Cited by 55
Kim, K. T., Rabinovitch, N., Uryniak, T. J., Simpson, B., O'Dowd, L. C., & Casty, F. E. (2004) · Annals of Allergy Asthma & Immunology · doi:10.1016/s1081-1206(10)61448-2 · Cited by 52
The diagnosis and treatment of adrenal insufficiency during childhood and adolescence
Park, J., Didi, M., & Blair, J. (2016) · Archives of Disease in Childhood · doi:10.1136/archdischild-2015-308799 · Cited by 47
Maguire, A., Biesheuvel, C. J., Ambler, G. R., Moore, B., McLean, M. P., & Cowell, C. T. C. T. (2007) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2007.03100.x · Cited by 53
di Iorgi, N., Napoli, F., Allegri, A., Secco, A., Calandra, E., Calcagno, A., Frassinetti, C., Ghezzi, M., Ambrosini, L., Parodi, S., et al. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2697 · Cited by 47
Liu, Q., Shi, W., Tian, L., Su, M., Jiang, M., Li, J., Gu, H., & Yu, C. (2021) · Analytica Chimica Acta · doi:10.1016/j.aca.2021.339010 · Cited by 47
Adrenal function testing in pediatric cancer survivors
Patterson, B. C., Truxillo, L., Wasilewski‐Masker, K., Mertens, A. C., & Meacham, L. R. (2009) · Pediatric Blood & Cancer · doi:10.1002/pbc.22208 · Cited by 43
Pelewicz, K., & Miśkiewicz, P. (2021) · Diagnostics · doi:10.3390/diagnostics11040728 · Cited by 44
“CRH stimulation test is not commonly used because of the high cost of the CRH peptide and low sensitivity for detecting AI [53].”
Group 2: Adrenal insufficiency: screening methods and confirmation of diagnosis
Chanson, P., Guignat, L., Goichot, B., Chabre, O., Samara‐Boustani, D., Reynaud, R., Simon, D., Tabarin, A., Gruson, D., Reznik, Y., et al. (2017) · Annales d Endocrinologie · doi:10.1016/j.ando.2017.10.005 · Cited by 43
Finucane, F. M., Liew, A., Thornton, E., Rogers, B., Tormey, W., & Agha, A. (2008) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2008.03240.x · Cited by 40
Izuchi, T., Iwama, S., Yamagami, A., Kobayashi, T., Suzuki, K., Murase, T., Ando, M., Murasawa, S., Mukai, K., Takagi, H., et al. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1741709 · Cited by 213
Berg, C., Meinel, T., Lahner, H., Mann, K., & Petersenn, S. (2010) · European Journal of Endocrinology · doi:10.1530/eje-09-0997 · Cited by 36
Self-citationFuchs, P. C., Gröger, A., Bozkurt, A., Johnen, D., Wolter, T. P., & Pallua, N. (2007) · Shock · doi:10.1097/shk.0b0318123e53b · Cited by 36
“The limits for adrenal insufficiency used in assessing the CRH test results were selected according to the parameters specified by the Institute for Clinical Chemistry and Pathobiochemistry at the Aachen University Hospital and to the cutoffs suggested by other authors (4, 21, 22).”
MethodEarly adrenocortical recovery after glucocorticoid therapy in children with leukemia
Cunha, C. D. F., Silva, I. N., & Finch, F. L. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031165 · Cited by 35
“Although the CRH stimulus test shows some benefit for the use in children, there is large interindividual variation on the response of ACTH and cortisol that limits its use in clinical practice (26, 28).”
Background(2013) · PubMed · Cited by 35
A Comprehensive Review of Empty Sella and Empty Sella Syndrome
Lundholm, M. D., & Yogi-Morren, D. (2024) · Endocrine Practice · doi:10.1016/j.eprac.2024.03.004 · Cited by 34
Ceccato, F., Tizianel, I., Vedolin, C. K., Boscaro, M., Barbot, M., & Scaroni, C. M. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa564 · Cited by 33
Huang, Y. (2015) · World Journal of Radiology · doi:10.4329/wjr.v7.i10.336 · Cited by 33
Prolactin and Other Pituitary Disorders in Kidney Disease
Huang, W., & Molitch, M. E. (2021) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2021.03.010 · Cited by 33
The Rational Use of Pituitary Stimulation Tests
Petersenn, S., QUABBE, H.-J., Schöfl, C., Stalla, G. K., von Werder, K., & Buchfelder, M. (2010) · Deutsches Ärzteblatt international · doi:10.3238/arztebl.2010.0437 · Cited by 47
Self-citationHusni, H., Abusamaan, M. S., Dinparastisaleh, R., Sokoll, L., Salvatori, R., & Hamrahian, A. H. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.978238 · Cited by 26
Lee, P., Greenfield, J. R., & Ho, K. K. Y. (2009) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2008.03466.x · Cited by 27
Weinstein, S. F., Qaqundah, P. Y., Georges, G. C., & Nayak, A. S. (2009) · Annals of Allergy Asthma & Immunology · doi:10.1016/s1081-1206(10)60340-7 · Cited by 29
A Contemporary Approach to the Diagnosis and Management of Adrenal Insufficiency
Charoensri, S., & Auchus, R. J. (2024) · Endocrinology and Metabolism · doi:10.3803/enm.2024.1894 · Cited by 28
“Additionally, some centers have used synthetic CRH to evaluate the function of the HPA axis; however, CRH testing has not been shown to be superior to CST, and CRH is no longer commercially available [22].”
MethodKumar, R., Carr, P., & Wassif, W. (2022) · Postgraduate Medical Journal · doi:10.1136/postgradmedj-2020-138514 · Cited by 23
Garrahy, A., & Agha, A. (2016) · BMC Endocrine Disorders · doi:10.1186/s12902-016-0117-7 · Cited by 23
“The CRF test is not widely used to assess the HPA axis due to its unacceptably low sensitivity [40].”
Secondary adrenal insufficiency: Where is it hidden and what does it look like?
Guaraldi, F., Karamouzis, I., Berardelli, R., D'Angelo, V., Rampino, A., Zichi, C., Ghigo, E., & Giordano, R. (2016) · Frontiers of hormone research · doi:10.1159/000443915 · Cited by 22
The impact of traumatic brain injury on pituitary function
Sundaram, N. K., Geer, E. B., & Greenwald, B. D. (2013) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2013.05.003 · Cited by 22
“5 mg/dL strongly indicates adrenal insufficiency, whereas a level greater than 18 mg/dL makes the diagnosis less likely.(70)”
BackgroundSidoroff, M., & Kolho, K. (2014) · BMC Gastroenterology · doi:10.1186/1471-230x-14-51 · Cited by 26
“However, studies have shown that serum morning cortisol levels under approximately 100 nmol/l are suggestive of adrenal insufficiency [11,22].”
Backgroundde Vries, F., Lobatto, D. J., Bakker, L. E. H., van Furth, W. R., Biermasz, N. R., & Pereira, A. M. (2019) · Endocrine · doi:10.1007/s12020-019-02094-6 · Cited by 25
“Studies have proposed different optimal cut-off values for early postoperative basal cortisol [14, 16].”
BackgroundYamagata, S., Kageyama, K., Takayasu, S., Asari, Y., Makita, K., Terui, K., & Daimon, M. (2019) · Internal Medicine · doi:10.2169/internalmedicine.3008-19 · Cited by 20
“The CRH test selectively stimulates the secretion of ACTH from pituitary corticotroph cells; it is therefore helpful for detecting secondary adrenal insufficiency due to pituitary dysfunction (21-23).”
BackgroundAdrenal insufficiency in HIV/AIDS: a review
Mifsud, S., Gauci, Z., Gruppetta, M., Mallia Azzopardi, C., & Fava, S. (2021) · Expert Review of Endocrinology & Metabolism · doi:10.1080/17446651.2021.1979393 · Cited by 19
Gasco, V., Bima, C., Geranzani, A., Giannelli, J., Marinelli, L., Bona, C., Cambria, V., Berton, A. M., Prencipe, N., Ghigo, E., et al. (2021) · Neuroendocrinology · doi:10.1159/000514216 · Cited by 18
Serum Morning Cortisol as A Screening Test for Adrenal Insufficiency
Montes‐Villarreal, J., Pérez-Arredondo, L. A., Rodríguez‐Gutiérrez, R., González-Colmenero, A. D., Solís, R. C., González‐González, J. G., & Mancillas‐Adame, L. G. (2019) · Endocrine Practice · doi:10.4158/ep-2019-0327 · Cited by 19
Anterior pituitary hormone replacement therapy—a clinical review
Auernhammer, C. J., & Vlotides, G. (2007) · Pituitary · doi:10.1007/s11102-007-0001-6 · Cited by 17
“6 lg/dl) is evidence of secondary adrenocortical insufficiency with 100% specificity but only 50% sensitivity [8, 9].”
BackgroundBrown, S. J., Hadlow, N. C., Badshah, I., & Henley, D. (2017) · Clinical Endocrinology · doi:10.1111/cen.13405 · Cited by 17
Burgers, A. M. G., Kokshoorn, N. E., Pereira, A. M., Roelfsema, F., Smit, J. W. A., Biermasz, N. R., & Romijn, J. A. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-2673 · Cited by 17
Kristof, R. A., Wichers, M., Haun, D., Redel, L., Klingmüller, D., & Schramm, J. (2008) · Acta Neurochirurgica · doi:10.1007/s00701-008-1517-x · Cited by 17
Minor and Repetitive Head Injury
Büki, A., Kovács, N., Czeiter, E., Schmid, K. E., Berger, R. P., Kobeissy, F. H., Italiano, D., Hayes, R. L., Tortella, F. C., Mezősi, E., et al. (2014) · Advances and technical standards in neurosurgery · doi:10.1007/978-3-319-09066-5_8 · Cited by 21
Sesmilo, G., Halperin, I., & Puig-Domingo, M. (2007) · HORMONES · doi:10.14310/horm.2002.1111013 · Cited by 14
“ing.(15,17) ACTH stimulation tests (low and standard dose) have been found to be of poor reliability in the diagnosis of adrenal deficiency in patients with baseline cortisol between 3.”
BackgroundHwang, Y.-A., Lee, H. W., Ahn, S. H., Lee, E. J., Ku, C. R., & Kim, S. U. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1057769 · Cited by 17
Guidelines for diagnosis and treatment of adrenal insufficiency in adults
Novoa, P. D. M., Vela, E. T., García, N. P., Rodríguez, M. M., Guerras, I. S., Santamaría, M. D. L. Á. M. D. S., & Aulinas, A. (2014) · Endocrinología y Nutrición (English Edition) · doi:10.1016/s2173-5093(14)70069-8 · Cited by 16
Pharmacological and analytical interference in hormone assays for diagnosis of adrenal incidentaloma
Lopez, A.-G., Fraissinet, F., Lefèbvre, H., Brunel, V., & Ziegler, F. (2019) · Annales d Endocrinologie · doi:10.1016/j.ando.2018.11.006 · Cited by 15
Nebennierenrinde und Steroide: Supplementäre Therapie in der perioperativen Phase
Milde, A. S., Böttiger, B. W., & Morcos, M. (2005) · Der Anaesthesist · doi:10.1007/s00101-005-0867-5 · Cited by 15
Bioletto, F., Berton, A. M., Varaldo, E., Cuboni, D., Bona, C., Parasiliti‐Caprino, M., Prencipe, N., Ghigo, E., Grottoli, S., Maccario, M., et al. (2022) · Journal of Endocrinological Investigation · doi:10.1007/s40618-022-01926-z · Cited by 13
Kokshoorn, N. E., Romijn, J. A., Roelfsema, F., Rambach, A. H., Smit, J. W. A., Biermasz, N. R., & Pereira, A. M. (2011) · Pituitary · doi:10.1007/s11102-011-0344-x · Cited by 14
Fleck, S. K., Wallaschofski, H., Rosenstengel, C., Matthes, M., Kohlmann, T., Nauck, M. A., Schroeder, H. W. S., & Spielhagen, C. (2013) · BMC Endocrine Disorders · doi:10.1186/1472-6823-13-51 · Cited by 13
“Corticotrophic deficiency: was defined as baseline cortisol < 100 nmol/l [19] or cortisol < 550 nmol/l following the ITT or low dose ACTH test.”
MethodCarmichael, J. D. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-804169-7.00010-6 · Cited by 14
Briet, C., Saraval, M., Loric, S., Topolinski-Duyme, H., Fendri, S., & Desailloud, R. (2007) · Annales d Endocrinologie · doi:10.1016/j.ando.2006.10.002 · Cited by 15
An audit of treatment outcome in acromegalic patients attending our center at Bergamo, Italy
Attanasio, R., Montini, M., Valota, M., Cortesi, L., Barbò, R., Biroli, F., Tonnarelli, G., Albizzi, M., Testa, R. M., & Pagani, G. A. (2007) · Pituitary · doi:10.1007/s11102-007-0059-1 · Cited by 13
“During the preceding years ovine corticotropin-releasing hormone test (100 lg iv) had been employed (setting at 15 lg/dL the cutoff for normal cortisol response) [ 12 ] in the context of the combined administration of multiple hypothalamic releasing hormones, whose results are not shown here.”
MethodLi, D., Pan, J., Peng, J., Zhang, S., Huang, G., Zhang, X., Bao, Y., & Qi, S. (2017) · Pediatric Research · doi:10.1038/pr.2017.289 · Cited by 12
Sanctis, V. D., Soliman, A. T., Elsedfy, H., Albu, A., Jaouni, S. A., Yaarubi, S. A., Anastasi, S., Canatan, D., Maio, M. D., Maio, S. D., et al. (2016) · Mediterranean Journal of Hematology and Infectious Diseases · doi:10.4084/mjhid.2016.034 · Cited by 13
Albert, L., Profitós, J., Sánchez‐Delgado, J., Capel, I., González-Clemente, J. M., Subías, D., Cano, A., Berlanga, E., Espinal, A., Hurtado, M., et al. (2019) · International Journal of Endocrinology · doi:10.1155/2019/7251010 · Cited by 12
Prencipe, N., Parasiliti‐Caprino, M., Gatti, F., Penner, F., Berton, A. M., Bona, C., Caputo, M., D’Angelo, V., Cappiello, V., Gasco, V., et al. (2020) · Neuroendocrinology · doi:10.1159/000509092 · Cited by 12
Steroid-Induced Iatrogenic Adrenal Insufficiency in Children: A Literature Review
Akahoshi, S., & Hasegawa, Y. (2020) · Endocrines · doi:10.3390/endocrines1020012 · Cited by 10
“Furthermore, early morning cortisol levels can also be used in screening [55,56] and assessment [57] of HPA function.”
BackgroundLi‐Ng, M., & Kennedy, L. (2012) · Journal of Surgical Oncology · doi:10.1002/jso.23207 · Cited by 11
“An early morning cortisol concentration of >15 mcg/dl (415 nmol/L) predicts a normal response to an ACTH stimulation test or to insulin-induced hypoglycemia [20].”
BackgroundHypopituitarism patterns among adult males with prolactinomas
Peng, J., Qiu, M., Qi, S., Li, D., & Peng, Y.-P. (2016) · Clinical Neurology and Neurosurgery · doi:10.1016/j.clineuro.2016.01.029 · Cited by 10
Funktionsdiagnostik in der Endokrinologie
Auernhammer, C. J., & Reincke, M. (2017) · Der Internist · doi:10.1007/s00108-017-0360-7 · Cited by 11
Hypophysen- und Nebennierenoperationen
Flohr, F., & Seufert, J. (2007) · Der Internist · doi:10.1007/s00108-007-1854-5 · Cited by 10
Colling, C., Nachtigall, L., Biller, B. M. K., & Miller, K. K. (2022) · Clinical Endocrinology · doi:10.1111/cen.14587 · Cited by 9
Papierska, L., Rabijewski, M., Migda, B., Leszczyńska, D., Nowak, K., Łebek-Szatańska, A., Glinicki, P., & Zgliczyński, W. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1004129 · Cited by 9
“CRH stimulation tests also give false negative results (FN), so can’t be recommended as a first-line diagnostic tool (15, 16).”
BackgroundAdrenocorticotropic Hormone Stimulation Test During High-Dose Glucocorticoid Therapy
Villabona, C. V., Koh, C.-K., Panergo, J., Reddy, A., & Fogelfeld, L. A. (2009) · Endocrine Practice · doi:10.4158/ep.15.2.122 · Cited by 9
Atluri, S., Sarathi, V., Goel, A., Shivaprasad, C., Alapaty, S., Dhananjaya, M. S., Barure, R., & Kolla, G. (2022) · Indian Journal of Endocrinology and Metabolism · doi:10.4103/ijem.ijem_461_21 · Cited by 9
“Several dynamic tests like the insulin tolerance test (ITT),[5,6] short synacthen test (SST),[6,7] low‐dose short synacthen test (LDSST),[7] corticotropin stimulating hormone (CRH) stimulation test,[8] and metyrapone challenge test,[9] have been evaluated with varied pros and cons.”
BackgroundMorning serum cortisol role in the adrenal insufficiency diagnosis with modern cortisol assays
Perozo, A. F. D. F., Fontes, R., Lopes, F. P., Araújo, P. B., Scrank, Y., Gomes, D. M. V., Moraes, A. B., & Neto, L. V. (2023) · Journal of Endocrinological Investigation · doi:10.1007/s40618-023-02062-y · Cited by 9
“…cutoff levels proposed in the literature (8, 9, 13 – 20] to confirm AI ( 3, 5 mcg/dL – 85, 140 nmol/L, respectively) and two MSC cutoff values proposed in the literature [9, 13, 14, 16, 17, 19–21] to exclude AI (> 10, > 15 mcg/dL – > 275, > 415 nmol/L, respectively) based on the CST result.”
Kano, T., Sugihara, H., Sudo, M., Nagao, M., Harada, T., Ishizaki, A., Nakajima, Y., Tanimura, K., Okajima, F., Tamura, H., et al. (2010) · Peptides · doi:10.1016/j.peptides.2009.12.023 · Cited by 11
Yeoh, P., Dwyer, A. A., Anghel, E., Bouloux, P. M., Khoo, B. C. E., Chew, S., Wernig, F., Carroll, P., Aylwin, S. J. B., Baldeweg, S. E., et al. (2022) · International Journal of Endocrinology · doi:10.1155/2022/7360282 · Cited by 8
“A number of studies have compared the ITT with alternative tests including morning cortisol [24, 25], ACTH stimulation test [26, 27], GHRH+ arginine [28], and glucagon [29].”
BackgroundNational German Audit of Diagnosis, Treatment, and Teaching in Secondary Adrenal Insufficiency
Petersenn, S., Honegger, J. B., & Quinkler, M. O. (2017) · Hormone and Metabolic Research · doi:10.1055/s-0043-105077 · Cited by 10
Self-citationSystemic Side Effects of Topical Corticosteroids
Ghosh, A., & Coondoo, A. (2017) · Springer eBooks · doi:10.1007/978-981-10-4609-4_25 · Cited by 13
Carmichael, J. D. (2010) · Elsevier eBooks · doi:10.1016/b978-0-12-380926-1.10010-0 · Cited by 8
A Prospective Analysis of the Metyrapone Short Test Using Targeted and Untargeted Metabolomics
Seoudy, A. K., Schlicht, K., Kulle, A. E., Demetrowitsch, T. J., Beckmann, A., Geisler, C., Türk, K., Rohmann, N., Hartmann, K., Brandes, J., et al. (2023) · Neuroendocrinology · doi:10.1159/000529146 · Cited by 8
Walter, M., McDonald, C. G., Paty, B. W., Shapiro, A. M. J., Ryan, E. A., & Senior, P. A. (2007) · Diabetic Medicine · doi:10.1111/j.1464-5491.2007.02048.x · Cited by 8
Hyponatremia in geriatric patients
Djukic, M., Grewe, J., Kunz, O., Groß, O., & Nau, R. (2024) · Zeitschrift für Gerontologie und Geriatrie · doi:10.1007/s00391-024-02342-z · Cited by 7
Challenging Diagnosis of Addison’s Disease Presenting with Adrenal Crisis
Dharmesti, N. W. W., Saraswati, M. R., Suastika, K., Gotera, W., & Dwipayana, I. M. P. (2021) · Case Reports in Endocrinology · doi:10.1155/2021/7137950 · Cited by 8
“…stimulation test, also known as cosyntropin test or ACTH test, is considered the gold standard for the diagnosis of primary adrenal in-sufficiency [17] and should be performed to confirm diagnosis in patients with clinical signs and symptoms of primary adrenal insufficiency, unless the results of…”
Huang, Z., Wu, J., Qi, J., Pan, C., Fu, J., & Hong, T. (2022) · World Neurosurgery · doi:10.1016/j.wneu.2022.09.006 · Cited by 7
Clinical course of primary empty sella in children: a singlecenter experience
Besci, Ö., Yaşar, E., Erbaş, İ. M., Acinikli, K. Y., Demir, K., Böber, E., & Abacı, A. (2022) · The Turkish Journal of Pediatrics · doi:10.24953/turkjped.2021.4953 · Cited by 5
Comment gérer l’arrêt d’une corticothérapie ?
Kuhn, J., & Prévost, G. (2014) · La Presse Médicale · doi:10.1016/j.lpm.2014.01.007 · Cited by 5
Metadata
- Authors
- Schmidt, I. L., Lahner, H., Mann, K., & Petersenn, S.
- Affiliations
- Stiftung Universitätsmedizin Essen (DE)
- Corresponding author
- Petersenn, S.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2003-09
- Volume
- 88
- Issue
- 9
- Pages
- 4193-4198
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W1982468989
- Cited by
- 149
- References
- 16
- Citations by year
- 2026: 5 · 2025: 4 · 2024: 8 · 2023: 5 · 2022: 10 · 2021: 12 · 2020: 8 · 2019: 8 · 2018: 1 · 2017: 10 · 2016: 10 · 2015: 9 · 2014: 7 · 2013: 4 · 2012: 3
- FWCI
- 1.81
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pituitary Gland Disorders and Treatments
- Keywords
- adrenal insufficiency, hypothalamic-pituitary-adrenal axis, corticotropin-releasing hormone test, insulin tolerance test, diagnostic accuracy, sensitivity and specificity
- MeSH terms
- Adrenal Gland Diseases, Adult, Corticotropin-Releasing Hormone, Female, Glucose Tolerance Test, Humans, Hydrocortisone, Hypothalamic Diseases, Insulin, Male, Predictive Value of Tests, Reference Values
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.